The relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients

Purpose: The results from Radiation Therapy Oncology Group (RTOG) 0617, a dose escalation trial that compared treatment with 60 Gy versus 74 Gy for patients with stage III non-small cell lung cancer (NSCLC), suggested that in these patients, the heart dose from radiation therapy correlates with surv...

Full description

Bibliographic Details
Main Authors: Laura K. McNew, MD, Stephen R. Bowen, PhD, Olga Gopan, PhD, Matthew J. Nyflot, PhD, Shilpen A. Patel, MD, Jing Zeng, MD, Ramesh Rengan, MD, PhD
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109417300131